Amazon Is Reaching Into The Healthcare Industry And Paul Mampilly Says This Could Cause Trouble
Paul Mampilly has seen Amazon grow from an online bookstore and secondhand goods seller to now becoming a giant that’s starting to monopolize various industries and its now rolling out plans for a new healthcare system. What usually happens is Amazon targets stocks of companies that have a chain of middlemen in them because it sells its customers the idea of transparency, and the healthcare industry is a maze of middlemen from pharmaceutical manufacturers to pharmacy chains, insurers and government agencies. Amazon is coming up with a system that could change all of that.
Amazon has announced that they’re going to partner with the big bank JP Morgan Chase and Warren Buffet’s Berkshire Hathaway firm. They plan on rolling out a healthcare system that can match customers with certain medications without needing the middleman’s operations and it’s going to be a form of non-profit though not in the traditional sense of the word. Paul Mampilly says this new format could definitely benefit consumers whose healthcare costs are going through the roof and need cheaper options, but it could spell death to traditional pharmacy companies and their stockholders. Mampilly is specifically warning his newsletter subscribers that if they see these low healthcare stocks that they need to stay away from them.
Paul Mampilly writes articles and in-depth newsletters that inform readers not only of which stocks they should avoid, but which ones could make them a lot of profits. Mampilly was originally an investment advisor for some of Wall Street’s top banks. He had completed his bachelor’s degree in finance prior to becoming a research assistant at Deutsche Bank, and from there he started managing millions of dollars in accounts for ING and Banker’s Trust. He served some notable billionaires and funds for international investment banks as Managing Director of Kinetics International Fund, and this hedge fund was grown from $6 billion to $25 billion in assets under management. Barron’s magazine even commended Mampilly for being able to spot investments that yielded upwards of 26% annually. Mampilly won the Templeton Foundation’s investment competition in 2009 for buying stocks over the previous year with $50 million, and then making a 76% gain without shorting them or buying into any high-risk ones.
Mampilly decided he no longer wanted to work for just the wealthy executives and big banks in 2012, so he left the corporate culture and decided to spend more time with family and focus on investing his own way. He also decided to let others in on his investment secrets and began writing for Banyan Hill in 2016. His first newsletter, “Profits Unlimited” began bringing newcomers into the investment world, and before long over 60,000 subscribers were reported who gave glowing reviews about what Mampilly’s advice had done for them. He has since started “Extreme Fortunes” and “True Momentum” for more advanced level investors and also has a YouTube channel that assists his followers even more. You can subscribe to Mampilly’s newsletters by going to www.banyanhill.com. Extreme Fortunes by Paul Mampilly, 10,000% Marijuana Stock